Paradromics

Paradromics develops a high-bandwidth implantable brain-computer interface, the Connexus Direct Data Interface, aimed first at restoring communication for people who have lost the ability to speak. After completing a first-in-human recording, the company advanced toward an FDA-approved clinical trial for speech restoration — placing it among the most clinically advanced of the brain-computer-interface companies, alongside Neuralink and Synchron. Its focus on data rate and a clear regulatory path has made it one of the most-watched names in neurotechnology.